Predictors of Stroke in Middle-Aged Patients With Non–Insulin-Dependent Diabetes
- 1 January 1996
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 27 (1), 63-68
- https://doi.org/10.1161/01.str.27.1.63
Abstract
Background and Purpose The risk of stroke is known to be markedly elevated in patients with non–insulin-dependent diabetes mellitus (NIDDM), but the information on risk factors predicting stroke events in middle-aged NIDDM patients is limited. Therefore, we evaluated the significance of different cardiovascular risk factors with respect to the incidence of stroke in middle-aged NIDDM patients. Methods Levels of cardiovascular risk factors were determined at baseline in 1059 NIDDM patients (581 men, 478 women) and 1373 nondiabetic control subjects (638 men, 735 women), aged from 45 to 64 years, in eastern and western Finland. These patients were followed up for 7 years with respect to stroke events. Results Altogether, 34 NIDDM patients (13 men, 21 women) and 5 nondiabetic subjects (4 men, 1 woman) died from stroke, and 125 NIDDM patients (61 men, 64 women) and 30 (18 men, 12 women) nondiabetic subjects had a fatal or nonfatal stroke. The risk of stroke in NIDDM men was about threefold and in NIDDM women fivefold higher than that in corresponding nondiabetic subjects. Previous history of stroke increased the risk of a new stroke event by threefold. Patients with hyperglycemia (plasma glucose >13.4 mmol/L) and high hemoglobin A 1 (>10.7%) had about a twofold higher risk of stroke than patients with better glycemic control. Low levels of high-density lipoprotein cholesterol (2.30 mmol/L), and the presence of hypertension were associated with a twofold increase in the risk of stroke mortality or morbidity. Conclusions Our prospective population-based study gives evidence that previous history of stroke, hypertension, hyperglycemia, and dyslipidemia are strong predictors of stroke in middle-aged patients with NIDDM.Keywords
This publication has 31 references indexed in Scilit:
- Platelet Plasminogen Activator Inhibitor 1 in Patients With Type II DiabetesDiabetes Care, 1994
- The Fibrinolytic Enzyme System and Its Role in the Etiology of Thromboembolic DiseaseSeminars in Thrombosis and Hemostasis, 1990
- Asymptomatic hyperglycemia is associated with lipid and lipoprotein changes favoring atherosclerosis.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1989
- Atherosclerotic Vascular Disease and Its Risk Factors in Non-Insulin-Dependent Diabetic and Nondiabetic Subjects in FinlandDiabetes Care, 1988
- Diabetes and atherosclerosis: An epidemiologic viewDiabetes/Metabolism Research and Reviews, 1987
- Plasma tissue plasminogen activator inhibitor levels in coronary artery disease: Correlation with age and serum triglyceride concentrationsJournal of the American College of Cardiology, 1987
- Increased Plasma Levels of a Rapid Inhibitor of Tissue Plasminogen Activator in Young Survivors of Myocardial InfarctionNew England Journal of Medicine, 1985
- Serum lipids and lipoproteins in middle-aged non-insulin-dependent diabeticsAtherosclerosis, 1985
- Role of residual insulin secretion in protecting against ketoacidosis in insulin-dependent diabetes.BMJ, 1979
- Radioimmunological determination of human C-peptide in serumDiabetologia, 1975